CrossRef Non-alcoholic fatty liver disease in Northeast India: a narrative review of rising metabolic syndrome Shiludi Longkumer, Maitrayee Dutta Swargiary Egyptian Liver Journal .2026;[Epub] CrossRef Doseresponse relationship between exercise and hepatic steatosis: A systematic review with Bayesian network meta-analysis of randomized controlled trials Xinyun Tan, Huihui Zou, Manjie Guo, Jiayu Liu, Xinjuan Huang, Ruoling Yu, Xuelian Liu, Chunxiang Qin Journal of Sport and Health Science .2026
Does impaired gastric emptying in diabetic patients alter the bioavailability of alpha-lipoic acid enantiomers
Type: Intensive Brightening and Spot Care Sheet Mask
Remington R, Chan A, Paskavitz J, Shea TB
When Eli Lilly published retatrutide's Phase 2 trial results in the New England Journal of Medicine in June 2023, the numbers got attention: participants on the highest dose lost an average of 24.2% of their body weight over 48 weeks
doi:10.1097/HEP.0000000000000323 5Targher G, Valenti L, Byrne CD